171 related articles for article (PubMed ID: 14566804)
21. Effect of poly (ethylene glycol) molecular weight and microparticle size on oral insulin delivery from P(MAA-g-EG) microparticles.
López JE; Peppas NA
Drug Dev Ind Pharm; 2004 May; 30(5):497-504. PubMed ID: 15244085
[TBL] [Abstract][Full Text] [Related]
22. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
Sajeesh S; Sharma CP
Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
[TBL] [Abstract][Full Text] [Related]
23. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy.
Tuesca A; Nakamura K; Morishita M; Joseph J; Peppas N; Lowman A
J Pharm Sci; 2008 Jul; 97(7):2607-18. PubMed ID: 17876768
[TBL] [Abstract][Full Text] [Related]
24. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery.
Sajeesh S; Bouchemal K; Sharma CP; Vauthier C
Eur J Pharm Biopharm; 2010 Feb; 74(2):209-18. PubMed ID: 19737614
[TBL] [Abstract][Full Text] [Related]
25. Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures.
Foss AC; Peppas NA
Eur J Pharm Biopharm; 2004 May; 57(3):447-55. PubMed ID: 15093592
[TBL] [Abstract][Full Text] [Related]
26. [Application of pH-responsive polymers to oral dosage forms for insulin].
Morishita M; Takayama K
Nihon Rinsho; 2001 Nov; 59(11):2255-60. PubMed ID: 11712416
[TBL] [Abstract][Full Text] [Related]
27. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics.
Nakamura K; Murray RJ; Joseph JI; Peppas NA; Morishita M; Lowman AM
J Control Release; 2004 Mar; 95(3):589-99. PubMed ID: 15023469
[TBL] [Abstract][Full Text] [Related]
28. Water, solute and protein diffusion in physiologically responsive hydrogels of poly (methacrylic acid-g-ethylene glycol).
Bell CL; Peppas NA
Biomaterials; 1996 Jun; 17(12):1203-18. PubMed ID: 8799505
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of pH-sensitive anionic hydrogel microparticles for oral protein-delivery applications.
Kim B; Lim SH; Ryoo W
J Biomater Sci Polym Ed; 2009; 20(4):427-36. PubMed ID: 19228445
[TBL] [Abstract][Full Text] [Related]
30. pH-Sensitive hydrogels as gastrointestinal tract absorption enhancers: transport mechanisms of salmon calcitonin and other model molecules using the Caco-2 cell model.
Torres-Lugo M; García M; Record R; Peppas NA
Biotechnol Prog; 2002; 18(3):612-6. PubMed ID: 12052080
[TBL] [Abstract][Full Text] [Related]
31. Release behaviour and biocompatibility of drug-loaded pH sensitive particles.
Sipahigil O; Gürsoy A; Cakalağaoğlu F; Okar I
Int J Pharm; 2006 Mar; 311(1-2):130-8. PubMed ID: 16427223
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles.
Ahmad N; Mohd Amin MC; Ismail I; Buang F
Expert Opin Drug Deliv; 2016; 13(5):621-32. PubMed ID: 26943455
[TBL] [Abstract][Full Text] [Related]
33. Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers.
Morishita M; Lowman AM; Takayama K; Nagai T; Peppas NA
J Control Release; 2002 May; 81(1-2):25-32. PubMed ID: 11992675
[TBL] [Abstract][Full Text] [Related]
34. Oral chemotherapeutic delivery: design and cellular response.
Blanchette J; Peppas NA
Ann Biomed Eng; 2005 Feb; 33(2):142-9. PubMed ID: 15771268
[TBL] [Abstract][Full Text] [Related]
35. Antiproteolytic action of orally delivered insulin using pH-responsive hydrogels in a rat burn model.
Madihally SV; Pantelogianis A; Toner M
J Surg Res; 2006 Sep; 135(1):187-94. PubMed ID: 16616764
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable hydrophilic carriers for the oral delivery of hematological factor IX for hemophilia B treatment.
Horava SD; Moy KJ; Peppas NA
Int J Pharm; 2016 Nov; 514(1):220-228. PubMed ID: 27863665
[TBL] [Abstract][Full Text] [Related]
37. Design of pH-Responsive Biomaterials to Enable the Oral Route of Hematological Factor IX.
Horava SD; Peppas NA
Ann Biomed Eng; 2016 Jun; 44(6):1970-82. PubMed ID: 26883955
[TBL] [Abstract][Full Text] [Related]
38. Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration.
Besheer A; Wood KM; Peppas NA; Mäder K
J Control Release; 2006 Mar; 111(1-2):73-80. PubMed ID: 16460830
[TBL] [Abstract][Full Text] [Related]
39. Poly(N-vinylcaprolactam-co-methacrylic acid) hydrogel microparticles for oral insulin delivery.
Mundargi RC; Rangaswamy V; Aminabhavi TM
J Microencapsul; 2011; 28(5):384-94. PubMed ID: 21736523
[TBL] [Abstract][Full Text] [Related]
40. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition.
Madsen F; Peppas NA
Biomaterials; 1999 Sep; 20(18):1701-8. PubMed ID: 10503971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
